138 related articles for article (PubMed ID: 24001610)
1. Nutlin-3 inhibits epithelial-mesenchymal transition by interfering with canonical transforming growth factor-β1-Smad-Snail/Slug axis.
Wu Y; Fu Y; Zheng L; Lin G; Ma J; Lou J; Zhu H; He Q; Yang B
Cancer Lett; 2014 Jan; 342(1):82-91. PubMed ID: 24001610
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
3. IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells.
Brandl M; Seidler B; Haller F; Adamski J; Schmid RM; Saur D; Schneider G
J Cell Sci; 2010 Dec; 123(Pt 24):4231-9. PubMed ID: 21081648
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine might inhibit TGF-beta1-induced epithelial-mesenchymal transition in NRK52E cells via Smad and PPAR-gamma pathway.
Wei J; Li Z; Yuan F
Cell Biol Int; 2014 Jul; 38(7):875-80. PubMed ID: 24604887
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
[TBL] [Abstract][Full Text] [Related]
6. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
Dong F; Liu T; Jin H; Wang W
Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
[TBL] [Abstract][Full Text] [Related]
7. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
8. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract][Full Text] [Related]
9. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition.
Shi J; Wang DM; Wang CM; Hu Y; Liu AH; Zhang YL; Sun B; Song JG
Cancer Res; 2009 Sep; 69(18):7180-7. PubMed ID: 19738073
[TBL] [Abstract][Full Text] [Related]
14. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
15. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
[TBL] [Abstract][Full Text] [Related]
16. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
Kim J; Hwan Kim S
PLoS One; 2013; 8(9):e74342. PubMed ID: 24023938
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 18 is necessary for initiation of TGF-β1-induced epithelial-mesenchymal transition in breast epithelial cells.
Jung H; Kim B; Moon BI; Oh ES
Mol Cell Biochem; 2016 Dec; 423(1-2):21-28. PubMed ID: 27734227
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-β1.
Saito K; Fukuda N; Shinohara K; Masuhiro Y; Hanazawa S; Matsuda H; Fujiwara K; Ueno T; Soma M
Int J Biochem Cell Biol; 2015 Sep; 66():112-20. PubMed ID: 26222185
[TBL] [Abstract][Full Text] [Related]
19. TRPC1/3/6 inhibition attenuates the TGF-β1-induced epithelial-mesenchymal transition in gastric cancer via the Ras/Raf1/ERK signaling pathway.
Ge P; Wei L; Zhang M; Hu B; Wang K; Li Y; Liu S; Wang J; Li Y
Cell Biol Int; 2018 Aug; 42(8):975-984. PubMed ID: 29570903
[TBL] [Abstract][Full Text] [Related]
20. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.
Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
Oncol Rep; 2017 Feb; 37(2):747-753. PubMed ID: 27959430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]